Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice.

Corona C, Frazzini V, Silvestri E, Lattanzio R, La Sorda R, Piantelli M, Canzoniero LM, Ciavardelli D, Rizzarelli E, Sensi SL.

PLoS One. 2011 Mar 15;6(3):e17971. doi: 10.1371/journal.pone.0017971.

2.

Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.

Eckert A, Schulz KL, Rhein V, Götz J.

Mol Neurobiol. 2010 Jun;41(2-3):107-14. doi: 10.1007/s12035-010-8109-5. Epub 2010 Mar 9. Review.

3.

[Pathological changes induced by amyloid-β in Alzheimer's disease].

Takata K, Kitamura Y, Taniguchi T.

Yakugaku Zasshi. 2011 Jan;131(1):3-11. Review. Japanese.

4.

Alzheimer's disease and amyloid: culprit or coincidence?

Skaper SD.

Int Rev Neurobiol. 2012;102:277-316. doi: 10.1016/B978-0-12-386986-9.00011-9. Review.

PMID:
22748834
5.

Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid.

Giménez-Llort L, Blázquez G, Cañete T, Johansson B, Oddo S, Tobeña A, LaFerla FM, Fernández-Teruel A.

Neurosci Biobehav Rev. 2007;31(1):125-47. Epub 2006 Oct 20. Review.

PMID:
17055579
6.

Therapeutic treatment of Alzheimer's disease using metal complexing agents.

Price KA, Crouch PJ, White AR.

Recent Pat CNS Drug Discov. 2007 Nov;2(3):180-7. Review.

PMID:
18221229
7.

Impaired transcription in Alzheimer's disease: key role in mitochondrial dysfunction and oxidative stress.

Caldeira GL, Ferreira IL, Rego AC.

J Alzheimers Dis. 2013;34(1):115-31. doi: 10.3233/JAD-121444. Review.

PMID:
23364141
8.

Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline.

Reddy PH, Manczak M, Mao P, Calkins MJ, Reddy AP, Shirendeb U.

J Alzheimers Dis. 2010;20 Suppl 2:S499-512. doi: 10.3233/JAD-2010-100504. Review.

9.

Insights into mitochondrial dysfunction: aging, amyloid-β, and tau-A deleterious trio.

Schmitt K, Grimm A, Kazmierczak A, Strosznajder JB, Götz J, Eckert A.

Antioxid Redox Signal. 2012 Jun 15;16(12):1456-66. doi: 10.1089/ars.2011.4400. Epub 2012 Jan 30. Review.

PMID:
22117646
10.

Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Disease.

Cabezas-Opazo FA, Vergara-Pulgar K, Pérez MJ, Jara C, Osorio-Fuentealba C, Quintanilla RA.

Oxid Med Cell Longev. 2015;2015:509654. doi: 10.1155/2015/509654. Epub 2015 Jun 29. Review.

11.

Testing the Amyloid Hypothesis with a Humanized AD Mouse Model.

Cahill MK, Huang EJ.

Neuron. 2017 Mar 8;93(5):987-989. doi: 10.1016/j.neuron.2017.02.044. Review.

PMID:
28279360
12.

Is interaction of amyloid β-peptides with metals involved in cognitive activity?

Tamano H, Takeda A.

Metallomics. 2015 Aug;7(8):1205-12. doi: 10.1039/c5mt00076a. Review.

PMID:
25959547
13.

The role of metals in modulating metalloprotease activity in the AD brain.

Filiz G, Price KA, Caragounis A, Du T, Crouch PJ, White AR.

Eur Biophys J. 2008 Mar;37(3):315-21. doi: 10.1007/s00249-007-0244-1. Epub 2008 Feb 13. Review.

PMID:
18270696
14.

Regulation of extracellular Zn(2+) homeostasis in the hippocampus as a therapeutic target for Alzheimer's disease.

Takeda A, Tamano H.

Expert Opin Ther Targets. 2015;19(8):1051-8. doi: 10.1517/14728222.2015.1029454. Epub 2015 Mar 27. Review.

PMID:
25818846
15.

Stabilizers of neuronal and mitochondrial calcium cycling as a strategy for developing a medicine for Alzheimer's disease.

Fernández-Morales JC, Arranz-Tagarro JA, Calvo-Gallardo E, Maroto M, Padín JF, García AG.

ACS Chem Neurosci. 2012 Nov 21;3(11):873-83. doi: 10.1021/cn3001069. Epub 2012 Aug 29. Review.

16.

Epilepsy and cognitive impairments in Alzheimer disease.

Palop JJ, Mucke L.

Arch Neurol. 2009 Apr;66(4):435-40. doi: 10.1001/archneurol.2009.15. Epub 2009 Feb 9. Review.

17.

Metals in Alzheimer's disease: a systemic perspective.

Squitti R.

Front Biosci (Landmark Ed). 2012 Jan 1;17:451-72. Review.

PMID:
22201755
18.

Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease?

Leuner K, Hauptmann S, Abdel-Kader R, Scherping I, Keil U, Strosznajder JB, Eckert A, Müller WE.

Antioxid Redox Signal. 2007 Oct;9(10):1659-75. Review.

PMID:
17867931
19.

Metals and cholesterol: two sides of the same coin in Alzheimer's disease pathology.

Wong BX, Hung YH, Bush AI, Duce JA.

Front Aging Neurosci. 2014 May 15;6:91. doi: 10.3389/fnagi.2014.00091. eCollection 2014. Review.

20.

Aging risk factors and Parkinson's disease: contrasting roles of common dietary constituents.

Hipkiss AR.

Neurobiol Aging. 2014 Jun;35(6):1469-72. doi: 10.1016/j.neurobiolaging.2013.11.032. Epub 2013 Dec 4. Review.

PMID:
24388766

Supplemental Content

Support Center